NIKKEI 225
38,490.17 -347.29 (-0.89%) HANG SENG
18,424.96 -19.15 (-0.10%) CRUDE OIL
74.18 +0.93 (+1.27%) GOLD FUTURES
2,375.80 +28.40 (+1.21%) DOW
38,809.34 +98.05 (+0.25%) Bitcoin GBP
55,554.71 +349.18 (+0.63%)
SAGE Nov 2024 20.000 call
| Previous close | 0.4500 |
| Open | 0.4500 |
| Bid | 0.3500 |
| Ask | 0.5000 |
| Strike | 20.00 |
| Expiry date | 2024-11-15 |
| Day's range | 0.4500 - 0.4500 |
| Contract range | N/A |
| Volume | |
| Open interest | 197 |
Business WireSage Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
CAMBRIDGE, Mass., June 05, 2024--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024, at 2:00 p.m. ET in Miami, FL.
- Investing.com
Baird predicts steady growth for SAGE Therapeutics at $15 target
Investing.com - Baird Equity Research has initiated coverage of SAGE Therapeutics Inc (NASDAQ:SAGE), assigning it a neutral rating with a price target of $15.
Insider Monkey15 Most Depressed States in the US
In this article, we will be taking a look at the 15 most depressed states in the US. If you are not interested in learning about the global and regional trends in the depression treatment market, head straight to the 5 Most Depressed States in the US. Global and Regional Trends in the Depression Treatment […]
